Xilio Therapeutics Inc. Soared
Thu, Mar 28, 2024 at 07:19 PM
Xilio Therapeutics Inc. (XLO:NASDAQ) soared at $1.08, representing a gain of 69%. On Thu, Mar 28, 2024, XLO:NASDAQ hit a New 2-Week High of $1.08. The stock appeared on our News Catalysts scanner on Thu, Mar 28, 2024 at 03:16 PM in the 'BIOTECH' category. From Thu, Mar 14, 2024, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Mar 28, 2024 at $1.93 with a volume of 33M+.
About Xilio Therapeutics Inc. (XLO:NASDAQ)
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 375%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 357.89%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 88.59%
- CERo Therapeutics Holdings Inc Com (CERO:NASDAQ), 88.34%
- Nexalin Technology Inc. (NXL:NASDAQ), 79.49%
- two Class A (TWOA:NYSE), 71.47%
- X3 Holdings Co Ltd Ord (New) US $ 0.40 (XTKG:NASDAQ), 70.53%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 69.01%
- Keyarch Acquisition Corporation (KYCH:NASDAQ), 67.35%
- Vinco Ventures Inc. (BBIG:NASDAQ), 60%